BMC Med Ethics. 2016 Oct 21;17(1):63.
Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.
Pulford DJ1, Harter P2, Floquet A3, Barrett C4, Suh DH5, Friedlander M6, Arranz JA7, Hasegawa K8, Tada H9,10, Vuylsteke P11, Mirza MR12, Donadello N13, Scambia G14, Johnson T15, Cox C15, Chan JK16, Imhof M17, Herzog TJ18, Calvert P19, Wimberger P20, Berton-Rigaud D21, Lim MC22, Elser G23, Xu CF15, du Bois A2.
This study was registered in the NCT Clinical Trial Registry under NCT00866697 on March 19, 2009, following approval from participating ethics committees (Additional file 1).
BRCA mutation; Bioethics; Incidental finding; Ovarian cancer; Pharmacogenetic research
- [PubMed - in process]